Coexistence of Histologically Confirmed Hashimoto's Thyroiditis with Different Stages of Papillary Thyroid Carcinoma in a Consecutive Chinese Cohort

View/ Open
Author
Liu, Xiaoyun
Zhu, Lijun
Cui, Dai
Wang, Zhixiao
Chen, Huanhuan
Duan, Yu
Shen, Meiping
Wu, Yunsong
Rong, Rong
Zhang, Zhihong
Wang, Xiaodong
Chen, Jiawei
Yang, Tao
Note: Order does not necessarily reflect citation order of authors.
Published Version
https://doi.org/10.1155/2014/769294Metadata
Show full item recordCitation
Liu, X., L. Zhu, D. Cui, Z. Wang, H. Chen, Y. Duan, M. Shen, et al. 2014. “Coexistence of Histologically Confirmed Hashimoto's Thyroiditis with Different Stages of Papillary Thyroid Carcinoma in a Consecutive Chinese Cohort.” International Journal of Endocrinology 2014 (1): 769294. doi:10.1155/2014/769294. http://dx.doi.org/10.1155/2014/769294.Abstract
Purpose. To determine the relationship between Hashimoto's thyroiditis (HT) and all stages of papillary thyroid carcinoma (PTC) with or without local lymph node metastasis (LNM). Methods:. We conducted a retrospective study of thyroidectomies from 2008–2013 in First Affiliated Hospital of Nanjing Medical University. We categorized patients according to the presence of histopathologically proven HT. The prevalence of mPTC (maximum diameter ≤ 10 mm) and crPTC (clinical relevant PTC) and local LNM rates were compared. Results:. We evaluated 6,432 consecutive thyroidectomies. In total, 1,328 specimens were confirmed as HT. The prevalence of PTC in this HT cohort was 43.8%, significantly higher than non-HT group. After adjustment of gender and age, the prevalence of PTC was still higher in HT group. HT was a risk factor for PTC in multivariate analysis with odds ratio 2.725 (95% CI, 2.390–3.109) (P < 0.001). However, no correlation was found between HT and LNM of PTC. Conclusion:. HT was associated with an increased prevalence of all stages of PTC, independent of tumor size, gender, and age. In contrast, locally advanced disease defined by LNM was unrelated to HT. These data suggest an association of HT with low risk PTC and a potential protective immunologic effect from further disease progression.Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4255062/pdf/Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:13581144
Collections
- HMS Scholarly Articles [17714]
Contact administrator regarding this item (to report mistakes or request changes)